**Core Concept**
The management of a patient with a mechanical heart valve on anticoagulation therapy during pregnancy requires careful consideration of the risks and benefits of continuing or adjusting anticoagulation therapy to minimize the risk of maternal and fetal complications, including valve thrombosis and fetal loss.

**Why the Correct Answer is Right**
Warfarin is a vitamin K antagonist that crosses the placenta and has a narrow therapeutic index, increasing the risk of fetal warfarin syndrome, which includes nasal hypoplasia, limb abnormalities, and intracranial calcifications. The American Heart Association recommends that women with mechanical heart valves on warfarin therapy be switched to low molecular weight heparin (LMWH) or unfractionated heparin during the first trimester of pregnancy to minimize this risk. In the second and third trimesters, warfarin may be continued, but with close monitoring of international normalized ratio (INR) levels.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while LMWH or unfractionated heparin may be used during pregnancy, they are not the only alternative to warfarin, and their use is not without risk, including heparin-induced thrombocytopenia.
**Option B:** This option is incorrect because aspirin has antiplatelet effects but does not provide adequate anticoagulation for patients with mechanical heart valves, and its use may not be sufficient to prevent valve thrombosis.
**Option C:** This option is incorrect because while warfarin is commonly used in patients with mechanical heart valves, it is not without risk during pregnancy, particularly in the first trimester when fetal warfarin syndrome is a concern.

**Clinical Pearl / High-Yield Fact**
The American Heart Association recommends that women with mechanical heart valves on warfarin therapy switch to LMWH or unfractionated heparin during the first trimester of pregnancy to minimize the risk of fetal warfarin syndrome.

**Correct Answer: A. This option is incorrect because while LMWH or unfractionated heparin may be used during pregnancy, they are not the only alternative to warfarin, and their use is not without risk, including heparin-induced thrombocytopenia.